Safety and pharmacodynamics of intranasal <scp>GSK</scp>2245035, a <scp>TLR</scp>7 agonist for allergic rhinitis: A randomized trialAnne K. Ellis, L. A. Lee, Wendy Powley et al.|Clinical & Experimental Allergy|2017Cited by 32
Canadian Society of Allergy and Clinical Immunology annual scientific meeting 2016Malcolm R. Sears, Mohammad A. Alsayegh, Hanan Alshamali et al.|Allergy Asthma and Clinical Immunology|2017Cited by 8